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Abstract
Clinical Question: Do patients treated for voice therapy with telepractice show similar changes in voice outcome 
measures as patients treated face-to-face? Method: Systematic Review. Study Sources: MEDLINE, PubMed, 
Google Scholar, ASHA journals. Search Terms: Voice therapy OR telepractice OR telehealth OR telerehabilitation. 
Number of Included Studies: 6. Primary Results: Delivery of voice therapy by telepractice provided positive 
outcomes comparable to face-to-face delivery. Number of studies employing quantitative data is relatively 
limited, restricting generalization of results. Conclusions: The goal of the speech-language pathologist is to 
maximize functional outcomes for individuals with communication disorders. Evidence found in this literature 
review for the effectiveness of telepractice delivery for the treatment of voice disorders indicates that treatment 
outcomes are comparable to face-to-face therapy and shows promising scope for this mode of service delivery.
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LB is a 47-year-old singer who performs in a nightclub 
three nights a week for about eight hours each night. 
He developed concerns with his voice characterized by 
complaints of vocal fatigue when talking (for more than 40 
minutes), intermittent glottal fry, and moderate raspiness 
at the end of the day. He also felt that he is producing his 
voice with increased effort compared to prior months. LB 
lives in a rural area and his primary-care physician referred 
him to the closest otolaryngology facility located three hours 
away from his home. After an interdisciplinary consult with 
the otolaryngologist, Dr. Collins, and the speech-language 
pathologist (SLP), Ms. Gina Martinez, LB was diagnosed 
with primary muscle tension dysphonia and recommended 
for voice therapy for five weeks. Unfortunately for LB, he 
may not be able to travel for three hours every week because 
of his busy work schedule. He may have to lose a part of his 
income if he decides to commute for his care; the situation 
has impacted LB’s quality-of-life substantially. Gina was 
interested in offering her services through telehealth, but 
had questions regarding the research evidence for voice 
therapy outcomes using telehealth. 
Background Information
The American Speech-Language-Hearing Association 
(ASHA) defines telepractice as the application of 
telecommunications technology to the delivery of speech-
language pathology and audiology professional services at a 
distance by linking clinician to client/patient or clinician to 
clinician for assessment, intervention, and/or consultation. 
Some of the early applications of telecommunications 
technology in speech-language pathology focused on 
diagnosis and treatment of neurogenic communication 
disorders. One of the first documented uses of telepractice 
was at the Birmingham Veteran’s Affairs Hospital (Vaughn, 
1976). Vaughn (1976) predominantly used the telephone 
to offer services related to assessment and treatment 
of communication impairments. Beginning in 1987, 
investigators at the Mayo Clinic provided speech-language 
pathology telepractice consultations for patients with 
communication disorders including dysarthria, apraxia, and 
cognitive-communicative impairments, and reported positive 
outcomes of telepractice (Duffy, Werven, & Aronson, 1997). 
Since the 1990s, ASHA has explored and emphasized 
research evidence related to telepractice and the potential of 
using this mode of service delivery for patients with speech-
language and hearing disorders. Due to improvements 
in technology and the ease of using telecommunications, 
telepractice has gained momentum and become a successful 
mode of assessment and treatment for various speech-
language, hearing, and swallowing disorders (Waite et al., 
2006; Hill, Theodoros, Russell, & Ward, 2009; Malandraki, 
McCullough, He, McWeeny, & Perlman, 2011). In spite of 
the potential significance of telepractice as a viable service-
delivery model, investigations on the efficacy of treatment 
are scant. Among the few investigations related to treatment, 
research related to voice therapy is minimal. Gina decided to 
complete a review of the available evidence for telepractice 
and voice therapy to understand the research evidence in this 
area to make informed decisions about her treatment plan. 
Clinical Question
Before starting her review, Gina decided to adopt the 
Population Intervention Comparison Outcome (PICO) model 
(Richardson, Wilson, Nishikawa, & Hayward, 1995) to frame 
her research question. Gina defined her parameters as follows: 
P (population): Individuals referred for voice therapy, 
but require or want services delivered via telepractice. 
I (intervention): Voice therapy delivered through 
telepractice. 
C (comparison): Outcomes of voice therapy delivered 
face-to-face. 
O (outcome): Changes in vocal measures (auditory/visual-
perceptual, acoustic, aerodynamic, or quality-of-life).
Gina identified her research question based on the 
PICO model: Do patients treated for voice therapy with 
telepractice show similar changes in voice outcome measures 
as patients treated face-to-face? 
Search for the Evidence
The purpose of Gina’s search was to gather evidence to 
answer her research question: Is there evidence to support 
equivalent outcomes of telepractice and face-to-face service-
delivery methods for individuals with voice disorders? She 
employed MEDLINE, PubMed, and Google Scholar to 
identify studies that addressed telepractice for voice therapy 
with the key words voice therapy, telepractice, telehealth, 
and telerehabilitation from 2000 to present. The search 
generated a total of 139 studies. Of these results, Gina 
filtered studies in the English language that reported voice 
treatment outcomes in individuals treated with telepractice. 
In order to obtain high-quality evidence, Gina decided to 
include articles reported in peer-reviewed journals only 
and articles that reported changes in at least one voice 
outcome measure (auditory/visual perceptual, aerodynamic, 
acoustic, quality-of-life). Gina included studies that used 
experimental, quasi-experimental, single-subject designs, or 
case study designs. She found that research related to voice 
therapy for specific voice disorders was very limited, so she 
chose to evaluate the evidence for all studies that addressed 
voice therapy through telepractice. At the outset, Gina read 
and reviewed the titles and the abstracts of all the articles. 
After reading the abstracts, Gina finally included six studies 
for the review that met the aforementioned criteria.
Search Strategy
Gina first sought to describe her studies in chronological 
order before evaluating the strength of evidence obtained 
from each of them. In one of the first studies discussing 
voice therapy and telepractice, Mashima et al. (2003) 
compared voice treatment delivered face-to-face and through 
telepractice for two groups of individuals with different 
laryngeal conditions including nodules, vocal fold paralysis, 
hyperfunction, and edema. Telepractice and face-to-face 
groups consisted of 23 and 28 individuals, respectively. 
Subjects were assigned to the groups randomly but matched 
for diagnostic category. Depending on the vocal pathology, 
the authors administered several treatment methods 
including facilitating voice treatment approaches (Boone, 
McFarlane, Von Berg, & Zraick, 2013), “confidential 
voice” (Colton & Casper, 1990), or vocal function exercises 
(Stemple, Glaze, & Gerdeman, 1995), in addition to 
vocal hygiene education. Outcome measures included 
auditory-perceptual and acoustic voice assessments, patient 
satisfaction, and laryngoscopic assessment. Posttreatment 
gains were shown in both groups and were comparable. 
In another study, Tindall, Huebner, Stemple, and 
Kleinert (2009) examined voice treatment outcomes 
delivered through videophone calling for a group of 24 
individuals with Parkinson’s disease treated through the Lee 
Silverman Voice Treatment (LSVT) method. They compared 
their results to a previously reported study (Ramig, Sapir, 
Fox, & Countryman, 2001) on individuals who were treated 
face-to-face with the same treatment method. The authors 
reported statistically significant improvement in vocal 
intensity and the results were similar to that obtained by 
Ramig et al. (2001) for face-to-face delivery of therapy.
Constantinescu et al. (2010, 2011) reported results 
from two studies investigating the utility of telepractice in 
voice treatment for individuals with Parkinson’s disease. In 
the first case report, Constantinescu et al. (2010) reported 
data from a patient with idiopathic Parkinson’s disease who 
was treated remotely for voice and speech impairments 
using LSVT and showed improvements in sound pressure 
levels, duration of sustained vowel production, vocal quality, 
intelligibility, and high satisfaction with the treatment. 
In another study, the same authors reported successful 
delivery of LSVT in 34 subjects with Parkinson’s disease and 
hypokinetic dysarthria (Constantinescu et al., 2011). 
More recently, Rangarathnam et al. (2015) and Fu, 
Theodoros, and Ward (2015) reported positive outcomes 
in individuals with primary muscle tension dysphonia 
(MTD) and bilateral vocal fold nodules respectively treated 
through telepractice. Rangarathnam et al. (2015) studied 
seven individuals with primary MTD treated face-to-
face and seven others through telepractice. The subjects 
underwent six weeks of treatment, which consisted of flow 
phonation exercises and vocal hygiene education. Significant 
improvements were reported in auditory-perceptual and 
quality-of-life measures and positive changes, although 
not statistically significant, on acoustic and aerodynamic 
measures. Fu et al. (2015) studied 10 female participants 
with bilateral vocal nodules who were treated with vocal 
hygiene education for the first session delivered face-to-
face followed by nine sessions of voice therapy through 
telepractice. The therapy included components of relaxation 
exercises (Verdolini Abbott, 2008), Lessac-Madsen Resonant 
Voice Therapy (Verdolini Abbott, 2008), and Vocal Function 
exercises (Stemple, Lee, D’Amico, & Pickup, 1994). 
Pre- and posttreatment outcomes consisted of auditory-
perceptual, acoustic, vocal fold function evaluated through 
videostroboscopy, and physiological measures obtained 
through aerodynamic analyses. In addition, the participants 
also completed the voice handicap index and a satisfaction 
questionnaire. Several of these measures, including overall 
severity on auditory perception, mucosal wave, glottal 
closure, mean airflow rate, and noise to harmonic ratio had 
significantly improved posttreatment and participants were 
generally satisfied with the telepractice delivery. 
Evaluating the Evidence
Gina adopted the guidelines provided by the Oxford 
Centre for Evidence-Based Medicine (OCEBM Levels of 
Evidence Working Group, 2009) to evaluate the strength of 
evidence obtained from the six articles. These guidelines are 
shown in Table 1. Gina provided an alphanumeric score to 
each of the studies based on these guidelines and also identified 
how these studies conform to the PICO model for her research 
question and presented these in tabular form (see Table 2). 
None of the six studies was a meta-analysis of more than 
one randomized control trial (RCT), which provides superior 
evidence. However, two of these six studies (Mashima et al., 
2003; Rangarathnam et al., 2015) were well controlled RCTs. 
Whereas the participants in the Mashima et al. study (2003) 
did not represent a homogenous sample or were provided one 
uniform treatment, those in the Rangarathnam et al. (2015) 
study were all patients with primary muscle tension dysphonia 
treated uniformly with the flow phonation exercises and 
vocal hygiene education. These were the only two studies that 
included a comparison group and provided strong support 
of the use of telepractice for patients with voice disorders—
primary muscle tension dysphonia in particular. This is 
further supported by data from well-controlled cohort studies 
of Tindall et al. (2009) and Constantinescu et al. (2011) for 
individuals with Parkinson’s disease and Fu et al. (2015) for 
women with vocal fold nodules. Even though these studies 
did not include a control group, two of these studies (Tindall 
et al., 2009; Fu et al., 2015) attempted to compare outcomes 
of other investigations that included face-to-face delivery. 
All of the studies reported changes in at least one outcome 
measure as an effect of therapy delivered through telepractice. 
The Evidence-Based Decision 
Gina carefully reviewed all her articles and the resulting 
evidence provided by each of them for her clinical research 
question: Can telepractice be successfully used to treat 
individuals with voice disorders with comparable changes 
in voice-related measures as an effect of voice therapy 
delivered face-to-face? Gina had a difficult decision to make 
primarily because of the overall lack of quantitative research 
in telepractice and voice therapy. Even though Gina had 
a wealth of information from the studies she reviewed, 
only two studies included a face-to-face group to compare 
the results of therapy delivered through telepractice. This 
was an important requirement in answering the clinical 
question based on the PICO model. Additionally, the study 
by Mashima et al. (2003) did not represent a group that 
received uniform treatment—this might be an important 
variable because one treatment method could be easier 
or difficult to administer from a distance compared to 
others. In other words, telepractice is only a different 
mode of delivering the same treatment method (and not a 
different treatment method altogether). This could impact 
appropriate interpretation of the data for Gina’s specific 
clinical research question. The study by Rangarathnam et al. 
(2015) did report uniform treatment to all the subjects who 
represented one clinical diagnostic entity of primary muscle 
tension dysphonia but the sample size in their study was 
relatively small (seven subjects in each group). 
Despite these disconcerting pieces of information, 
Gina was convinced in making an informed decision that 
there was evidence that telepractice may be a viable option 
for LB. Gina’s decision was based on several important 
considerations. First, the studies by Mashima et al. (2003) 
and Rangarathnam et al. (2015) were randomized control 
designs and demonstrated clinically significant changes. 
Second, the collective evidence from these studies was 
positive and the data were complementary: the Mashima 
et al. (2003) study included a larger sample size and the 
Rangarathnam et al. (2015) study provided data from 
a highly homogenous sample that provided uniform 
treatment. Third, both studies included a control group and 
demonstrated changes in several voice outcome measures–
namely auditory-perceptual, acoustic, aerodynamic, and 
subjects’ own perception of the problem; the results in the 
experimental and control group were largely similar. Lastly, 
even though the levels of evidence were relatively weaker 
for the remaining studies, they did demonstrate changes in 
outcome measures in a single cohort of subjects who were 
provided voice therapy through telepractice. 
The goal of the speech-language pathologist is to 
maximize functional outcomes for individuals with 
communication disorders. Some individuals, like LB, 
who live in areas far from a healthcare facility that offers 
speech-language pathology services, demonstrate hardships 
in general livelihood because of the impact on regular 
income and reduction in their quality-of-life. Others 
may have mobility or transportation issues, may be 
immunocompromised, may have a conflict of interest with a 
therapist, or may simply desire to be seen by an expert voice 
therapist rather than a general speech-language pathologist. 
All of these concerns may warrant seeking services through 
telepractice. Gina’s review of the few articles available offers 
some promise regarding the potential use of telepractice for 
delivering voice therapy. The impact could be as substantial 
as improving health care and cutting costs to consumers. 
Gina was cautious in interpreting these data as there are a 
wide variety of voice disorders and treatments and different 
treatments may be more suited for telepractice than 
others. It may not be necessary to provide data supporting 
every available type of voice therapy method for use with 
telepractice, but interpretations based on the few available 
studies need to be considered conscientiously. 
Authors’ Notes
Balaji Rangarathnam, PhD, is an assistant professor in 
the Department of Communication Sciences and Disorders 
at East Carolina University. His professional interests relate 
to voice and swallowing disorders and their treatment.
Haley Gilroy, BA, is a graduate student in speech-
language pathology at East Carolina University. Her 
interests relate to voice disorders. 
Gary H. McCullough, PhD, is a professor and associate 
dean for Research and Graduate Education in the Beaver 
College of Health Sciences at Appalachian State University, 
Boone, NC. His professional interests relate to assessment 
and treatment of swallowing and voice disorders. 
Balaji Rangarathnam, PhD
East Carolina University
Department of Communication Sciences and Disorders
600 Moye Blvd., Health Sciences Bldg.,
CSDI Mailstop 668
Greenville, NC 27834 
E-mail: rangarathnamb@ecu.edu
References
Boone, D. R., McFarlane, S. C., Von Berg, S. L., & Zraick, 
R. I. (2013). The voice and voice therapy (9th ed.).
Boston, MA: Pearson.
Colton, R. H., & Casper, T. K. (1990). Understanding voice 
problems: A physiological perspective for diagnosis and 
treatment (2nd ed.). Baltimore, MD: Williams & Wilkins.
Constantinescu, G. A., Theodoros, D. G., Russell, T. G., 
Ward, E. C., Wilson, S. J., & Wootton, R. (2010). 
Home-based speech treatment for Parkinson’s 
disease delivered remotely: A case report. Journal 
of Telemedicine and Telecare, 16(2), 100–104. 
doi:10.1258/jtt.2009.090306
Constantinescu, G., Theodoros, D., Russell, T., Ward, E., 
Wilson, S., & Wootton, R. (2011). Treating disordered 
speech and voice in Parkinson’s disease online: A 
randomized controlled noninferiority trial. International 
Journal of Language & Communication Disorders, 46(1), 
1–16. doi:10.3109/13682822.2010.484848
Duffy, J. R., Werven, G. W., & Aronson, A. E. (1997). 
Telemedicine and the diagnosis of speech and language 
disorders. Mayo Clinic Proceedings, 72(12), 1116–1122. 
doi:10.4065/72.12.1116
Fu, S., Theodoros, D. G., & Ward, E. C. (2015). Delivery 
of intensive voice therapy for vocal fold nodules via 
telepractice: A pilot feasibility and efficacy study. 
Journal of Voice, 29(6), 696–706. doi:10.1016/j.
jvoice.2014.12.003
Hill, A. J., Theodoros, D. G., Russell, T. G., & Ward, E. C. 
(2009). The redesign and re-evaluation of an internet-
based telerehabilitation system for the assessment of 
dysarthria in adults. Telemedicine and e-Health, 15(9), 
840–850. doi:10.1089/tmj.2009.0015
Malandraki, G. A., McCullough, G., He, X., McWeeny, 
E., & Perlman, A. L. (2011). Teledynamic evaluation 
of oropharyngeal swallowing. Journal of Speech, 
Language, and Hearing Research, 54(6), 1497–1505. 
doi:10.1044/1092-4388(2011/10-0284)
Mashima, P. A., Birkmire-Peters, D. P., Syms, M. J., 
Holtel, M. R., Burgess, L. P. A., & Peters, L. J. (2003). 
Telehealth voice therapy using telecommunications 
technology. American Journal of Speech-Language 
Pathology, 12(4), 432–439. doi:10.1044/1058-
0360(2003/089)
OCEBM Levels of Evidence Working Group. (2009). The 
Oxford Levels of Evidence. Retrieved from http://www.
cebm.net/oxford-centre-evidence-based-medicine-
levels-evidence-march-2009/
Ramig, L. O., Sapir, S., Fox, C., & Countryman, S. 
(2001). Changes in vocal loudness following 
intensive voice treatment (LSVT®) in individuals with 
Parkinson’s disease: A comparison with untreated 
patients and normal age-matched controls. Movement 
Disorders, 16(1), 79–83. doi:10.1002/1531-
8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H
Rangarathnam, B., McCullough, G. H., Pickett, H., Zraick, 
R. I., Tulunay-Ugur, O., & McCullough, K. C. (2015).
Telepractice versus in-person delivery of voice therapy
for primary muscle tension dysphonia. American
Journal of Speech-Language Pathology, 24(3), 386–399.
doi:10.1044/2015_AJSLP-14-0017
Richardson, W. S., Wilson, M. C., Nishikawa, J., & 
Hayward, R. S. A. (1995). The well-built clinical 
question: A key to evidence-based decisions. ACP J 
Club, 123(3), A12. doi:10.7326/ACPJC-1995-123-
3-A12
Stemple, J. C., Glaze, L. E., & Gerdeman, B. K. (1995). 
Clinical voice pathology (2nd ed.). San Diego, CA: 
Singular Publishing Group.
Stemple, J. C., Lee, L., D’Amico, B., & Pickup, B. (1994). 
Efficacy of vocal function exercises as a method of 
improving voice production. Journal of Voice, 8(3), 
271–278. doi:10.1016/S0892-1997(05)80299-1
Tindall, L. R., Huebner, R. A., Stemple, J. C., & Kleinert, 
H. L. (2009). Videophone-delivered voice therapy:
A comparative analysis of outcomes to traditional
delivery for adults with Parkinson’s disease. Telemedicine
and e-Health, 14(10), 1070–1077. doi:10.1089/
tmj.2008.0040
Vaughn, G. R. (1976). Tel-communicology: Health-care 
delivery system for persons with communicative 
disorders. ASHA, 18(1), 13–17.
Verdolini Abbott, K. (2008). Lessac-Madsen Resonant Voice 
Therapy Clinician Manual. San Diego, CA: Plural 
Publishing, Inc.
Waite, K., Silver, F., Jaigobin, C., Black, S., Lee, L., 
Murray, B., . . . Brown, E. M. (2006). Telestroke: A 
multi-site, emergency-based telemedicine service in 
Ontario. Journal of Telemedicine and Telecare, 12(3), 
141–145.
Table 1. Oxford Centre of Evidence-Based Medicine (OCEBM) Levels of Evidence*
1a Systematic reviews (with homogeneity) of randomized controlled trials
1b Individual randomized controlled trials (with narrow confidence interval)
1c All or none randomized controlled trials
2a Systematic reviews (with homogeneity) of cohort studies
2b Individual cohort study or low-quality randomized controlled trials (e.g., < 80% follow-up)
2c “Outcomes” Research; ecological studies
3a Systematic review (with homogeneity) of case-control studies
3b Individual case-control study
4 Case series (and poor quality cohort and case-control studies)
5 Expert opinion without explicit critical appraisal, or based on physiology, bench research, or “first principles”
* OCEBM Working Group (2009)












Mashima et al. (2003) X X X X 1b
Tindall, Huebner, Stemple, & Kleinert (2009) X X X 2b
Constantinescu et al. (2010) X X X 3b
Constantinescu et al. (2011) X X X 2b
Rangarathnam et al. (2015) X X X X 1b
Fu, Theodoros, & Ward (2015) X X X 2b
